Literature DB >> 1975565

Restriction fragment length polymorphism analysis of the L-myc gene locus in a case-control study of lung cancer.

S Tamai1, H Sugimura, N E Caporaso, J H Resau, B F Trump, A Weston, C C Harris.   

Abstract

The L-myc DNA-restriction fragment length polymorphism, revealed by EcoRI, has been studied in both a lung cancer case-control framework and a cohort of 40 non-diseased unrelated individuals. No association was found between the L-myc allelic frequencies and disease status, tumor stage or lung cancer histology. A strong association was, however, observed between the L-myc allelic frequencies and ethnic origin (black or white) of the subjects. Among American whites the allelic distribution at the L-myc proto-oncogene locus was almost identical to that previously reported for Japanese subjects. Among the American black population there was a significantly higher frequency of the presence of the polymorphic EcoRI restriction site in the second intron of the L-myc proto-oncogene. These data emphasize the importance of conducting epidemiologic studies that control for ethnic factors and indicate that L-myc EcoRI allelotypes do not appear to be predictive of lung cancer risk or disease status in American blacks and whites.

Entities:  

Mesh:

Year:  1990        PMID: 1975565     DOI: 10.1002/ijc.2910460314

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  7 in total

1.  A 5'-region polymorphism modulates promoter activity of the tumor suppressor gene MFSD2A.

Authors:  Francesca Colombo; Felicia S Falvella; Antonella Galvan; Elisa Frullanti; Hideo Kunitoh; Toshikazu Ushijima; Tommaso A Dragani
Journal:  Mol Cancer       Date:  2011-07-07       Impact factor: 27.401

2.  Statistical models for genetic susceptibility in toxicological and epidemiological investigations.

Authors:  W W Piegorsch
Journal:  Environ Health Perspect       Date:  1994-01       Impact factor: 9.031

3.  MYCL genotypes and loss of heterozygosity in non-small-cell lung cancer.

Authors:  K M Fong; Y Kida; P V Zimmerman; P J Smith
Journal:  Br J Cancer       Date:  1996-12       Impact factor: 7.640

4.  L-myc restriction fragment length polymorphism in Japanese patients with esophageal cancer.

Authors:  K Shibuta; H Inoue; K Sato; A Matsuyama; H Ueo; Y Tanaka; K Mafune; G F Barnard; M Mori
Journal:  Jpn J Cancer Res       Date:  2000-02

5.  Different susceptibility of each L-myc genotype to esophageal cancer risk factors.

Authors:  H Kumimoto; N Hamajima; K Nishizawa; Y Nishimoto; K Matsuo; H Harada; M Shinoda; S Hatooka; K Ishizaki
Journal:  Jpn J Cancer Res       Date:  2001-07

6.  Relationship of H-ras-1, L-myc, and p53 polymorphisms with lung cancer risk and prognosis.

Authors:  A Weston; N E Caporaso; L S Perrin; H Sugimura; S Tamai; T G Krontiris; B F Trump; R N Hoover; C C Harris
Journal:  Environ Health Perspect       Date:  1992-11       Impact factor: 9.031

7.  Increased frequency of the S allele of the L-myc oncogene in non-Hodgkin's lymphoma.

Authors:  P E Crossen; M J Morrison; B M Colls
Journal:  Br J Cancer       Date:  1994-04       Impact factor: 7.640

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.